Response to the Accelerated Access Review

In response to the publication of the review, Jeremy Farrar, Wellcome's Director, said: “The UK can become the best place in the world to develop, test and roll out new healthcare innovations if we realise the full potential of the research base, industrial partnerships, patient capital and the NHS.

“The review is a first step towards building the right environment and infrastructure within the NHS. It sets out an achievable strategy for getting the most promising drugs, devices, digital products and diagnostics to patients quickly, and transforming lives. Its success will depend on the close involvement of all stakeholders, and will need dedicated funding from the government to support implementation.”